Anagenics Limited (ASX:AN1) Insider Alexander (Sandy) Beard Acquires 1,950,000 Shares

Anagenics Limited (ASX:AN1Get Free Report) insider Alexander (Sandy) Beard purchased 1,950,000 shares of the business’s stock in a transaction on Wednesday, May 7th. The shares were bought at an average cost of A$0.01 ($0.00) per share, for a total transaction of A$13,650.00 ($8,750.00).

Alexander (Sandy) Beard also recently made the following trade(s):

  • On Monday, May 12th, Alexander (Sandy) Beard bought 226,876 shares of Anagenics stock. The stock was acquired at an average cost of A$0.01 ($0.00) per share, for a total transaction of A$1,361.26 ($872.60).
  • On Thursday, May 8th, Alexander (Sandy) Beard bought 267,555 shares of Anagenics stock. The stock was acquired at an average cost of A$0.01 ($0.00) per share, for a total transaction of A$1,605.33 ($1,029.06).
  • On Monday, May 5th, Alexander (Sandy) Beard bought 1,734,067 shares of Anagenics stock. The stock was acquired at an average cost of A$0.01 ($0.00) per share, for a total transaction of A$12,138.47 ($7,781.07).

Anagenics Price Performance

The company has a current ratio of 1.21, a quick ratio of 1.15 and a debt-to-equity ratio of 28.51. The company has a market cap of $3.69 million, a P/E ratio of -0.38 and a beta of -1.03.

About Anagenics

(Get Free Report)

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names.

Further Reading

Receive News & Ratings for Anagenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anagenics and related companies with MarketBeat.com's FREE daily email newsletter.